Discover a study that examined the efficacy and safety of pemafibrate in 360 patients with MASLD and hypertriglyceridaemia.

Denifanstat treatment significantly improves liver disease activity among individuals with metabolic dysfunction-associated steatohepatitis.

The patient, who suffered from advanced liver cancer was enrolled in the former Can-Fite Phase II study, continue to be treated with Namodenoson, and has now an overall survival of 8 years, with ...

There are plenty of reasons why you might notice some redness, itching or inflammation on your face. In fact, everything from ...

Liver transplants offer a life-changing solution for chronic liver failure, improving survival rates, energy levels, and ...

Fatty liver disease is a growing health concern that often develops silently, showing no clear symptoms in its early stages.

Dr. Ben Galyardt told Newsweek: "There is no drug that will treat fatty liver. There is no surgery that will fix it." ...

Liver-specific SMN1 gene therapy both improved liver functioning, and also reduced other SMA-like symptoms in a mouse model ...

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk patients through the power of dynamic biopsy technology, today announced ...

When a company's shares shoot up 82% in 12 months, investors clearly think it's a good time to be a shareholder -- and that's exactly what's happened to the stock of Madrigal Pharmaceuticals (NASDAQ: ...

Severe obesity is a major health issue around the world, increasing the risk of many diseases, including diabetes, heart ...